Re-challenge of immune checkpoint inhibitor pembrolizumab with concurrent tocilizumab after prior grade 3 pneumonitis
Article in Ecancermedicalscience (December 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Ecancermedicalscience (December 2023)
Article in Cancers (April 2023)
Article in Frontiers in Oncology (April 2023)